We offer full support, from corporate governance to capital market, to help WellJoint (Shanghai) Technology make a stand in the industry, become a listed company, and achieve milestones along the way.

China Development Industrial Bank was officially renamed CDIB Capital Group with this underlying business transformation in March 2017. This evolution is underpinned by the goal of becoming the leading private equity and venture capital fund manager in the Asia-Pacific region.

Later that year, CDIB was formally engaged by China Life Insurance Company (now renamed as KGI Life Insurance Company) to be their Investment Advisor. Customized Fund investment Programs. CDIB establishes customized fund investment programs in close collaboration with clients. The fund program aims to create well balanced and diversified ...

cdib capital group invests in ai fund, a leading silicon valley venture studio

We seek to invest alongside top tier private equity fund managers, leveraging on CDIB Capital’s direct investment expertise and the broader KGI Financial platform, with its broad network of relationships with the world’s best private equity funds, leading to attractive and best-in-class investment opportunities.

We seek to invest alongside top tier private equity fund managers, leveraging on CDIB Capital’s direct investment expertise and the broader KGI Financial platform, with its broad network of relationships with the world’s best private equity funds, leading to attractive and best-in-class investment opportunities.

We aim to capture recurring, high yielding cash returns through investing in bespoke and defensively structured, secured debt packages and securitizations of performing and growing middle market borrowers.

Founded in 1982, PT MedTech is a total solution contract manufacturer of cable and wire harness assemblies, components, sub-assemblies and final assemblies for medical devices in China, directly serving a solid and entrenched customer base consisting of Fortune 500 corporates, multinational medical device suppliers, emerging medical technology companies, and specialized provider of surgical ...

We pursue opportunistic investments that achieve attractive risk-adjusted returns, primarily in North America and Asia Pacific. We also invest across the capital structure in control and non-control situations, and are industry-agnostic.

Successfully executed CDIB’s transformation from an industrial bank to an asset manager, now with regional footprints across North America and Asia, investment teams of 100+ professionals and external AUM of NT$50bn+.